Skip to main content
Top
Published in: Neurological Sciences 1/2020

01-01-2020 | Stroke | Brief Communication

Diffuse alveolar hemorrhage following intravenous thrombolytic treatment in acute ischemic stroke: a case series

Authors: Murat Mert Atmaca, Ugur Burak Simsek, Ipek Midi, Rustem Aliev, Emrah Aytac, Mehtap Kocaturk

Published in: Neurological Sciences | Issue 1/2020

Login to get access

Abstract

Diffuse alveolar hemorrhage (DAH) following fibrinolytic therapy is a rare but a life-threatening complication. In acute ischemic stroke (AIS), DAH as a complication was not reported following intravenous thrombolytic therapy (ITT). The demographic, clinical, radiologic, and prognostic data of 4 patients with AIS who developed DAH after ITT are presented in this case series, along with a literature review.
Literature
1.
go back to reference Nasser M, Cottin V (2018) Alveolar hemorrhage in vasculitis (primary and secondary). Semin Respir Crit Care Med 39:482–493CrossRef Nasser M, Cottin V (2018) Alveolar hemorrhage in vasculitis (primary and secondary). Semin Respir Crit Care Med 39:482–493CrossRef
2.
go back to reference Newsome BR, Morales JE (2011) Diffuse alveolar hemorrhage. South Med J 104:269–274CrossRef Newsome BR, Morales JE (2011) Diffuse alveolar hemorrhage. South Med J 104:269–274CrossRef
3.
go back to reference Schwarz MI, Fontenot AP (2004) Drug-induced diffuse alveolar hemorrhage syndromes and vasculitis. Clin Chest Med 25:133–140CrossRef Schwarz MI, Fontenot AP (2004) Drug-induced diffuse alveolar hemorrhage syndromes and vasculitis. Clin Chest Med 25:133–140CrossRef
4.
go back to reference Heslet L, Nielsen JD, Nepper-Christensen S (2012) Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) - a review of a new treatment paradigm. Biologics 6:37–46PubMedPubMedCentral Heslet L, Nielsen JD, Nepper-Christensen S (2012) Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) - a review of a new treatment paradigm. Biologics 6:37–46PubMedPubMedCentral
5.
go back to reference Rabe C, Appenrodt B, Hoff C, Ewig S, Klehr HU, Sauerbruch T, Nickenig G, Tasci S (2010) Severe respiratory failure due to diffuse alveolar hemorrhage: clinical characteristics and outcome of intensive care. J Crit Care 25:230–235CrossRef Rabe C, Appenrodt B, Hoff C, Ewig S, Klehr HU, Sauerbruch T, Nickenig G, Tasci S (2010) Severe respiratory failure due to diffuse alveolar hemorrhage: clinical characteristics and outcome of intensive care. J Crit Care 25:230–235CrossRef
6.
go back to reference Yigla M, Sprecher E, Azzam Z, Guralnik L, Kapeliovich M, Krivoy N (2000) Diffuse alveolar hemorrhage following thrombolytic therapy for acute myocardial infarction. Respiration 67:445–448CrossRef Yigla M, Sprecher E, Azzam Z, Guralnik L, Kapeliovich M, Krivoy N (2000) Diffuse alveolar hemorrhage following thrombolytic therapy for acute myocardial infarction. Respiration 67:445–448CrossRef
7.
go back to reference Narayanan S, Thulaseedharan NK, Subramaniam G, Panarkandy G, Arathi N (2017) Pulmonary alveolar hemorrhage following thrombolytic therapy. Int Med Case Rep J 10:123–125CrossRef Narayanan S, Thulaseedharan NK, Subramaniam G, Panarkandy G, Arathi N (2017) Pulmonary alveolar hemorrhage following thrombolytic therapy. Int Med Case Rep J 10:123–125CrossRef
8.
go back to reference Nathan PE, Torres AV, Smith AJ, Gagliardi AJ, Rapeport KB (1992) Spontaneous pulmonary hemorrhage following coronary thrombolysis. Chest 101:1150–1152CrossRef Nathan PE, Torres AV, Smith AJ, Gagliardi AJ, Rapeport KB (1992) Spontaneous pulmonary hemorrhage following coronary thrombolysis. Chest 101:1150–1152CrossRef
9.
go back to reference Gopalakrishnan D, Tioran T, Emanuel C, Clark VL (1997) Diffuse pulmonary hemorrhage complicating thrombolytic therapy for acute myocardial infarction. Clin Cardiol 20:298–300CrossRef Gopalakrishnan D, Tioran T, Emanuel C, Clark VL (1997) Diffuse pulmonary hemorrhage complicating thrombolytic therapy for acute myocardial infarction. Clin Cardiol 20:298–300CrossRef
10.
go back to reference Iskandar SB, Kasasbeh ES, Mechleb BK, Garcia I, Jackson A, Fahrig S, Albalbissi K, Henry PD (2006) Alveolar hemorrhage: an underdiagnosed complication of treatment with glycoprotein IIb/IIIa inhibitors. J Interv Cardiol 19:356–363CrossRef Iskandar SB, Kasasbeh ES, Mechleb BK, Garcia I, Jackson A, Fahrig S, Albalbissi K, Henry PD (2006) Alveolar hemorrhage: an underdiagnosed complication of treatment with glycoprotein IIb/IIIa inhibitors. J Interv Cardiol 19:356–363CrossRef
11.
go back to reference Kalra S, Bell MR, Rihal CS (2001) Alveolar hemorrhage as a complication of treatment with abciximab. Chest 120:126–131CrossRef Kalra S, Bell MR, Rihal CS (2001) Alveolar hemorrhage as a complication of treatment with abciximab. Chest 120:126–131CrossRef
12.
go back to reference Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, Bluhmki E, Bouvaist H, Brenner B, Couturaud F, Dellas C, Empen K, Franca A, Galie N, Geibel A, Goldhaber SZ, Jimenez D, Kozak M, Kupatt C, Kucher N, Lang IM, Lankeit M, Meneveau N, Pacouret G, Palazzini M, Petris A, Pruszczyk P, Rugolotto M, Salvi A, Schellong S, Sebbane M, Sobkowicz B, Stefanovic BS, Thiele H, Torbicki A, Verschuren F, Konstantinides SV (2014) Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 370:1402–1411CrossRef Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, Bluhmki E, Bouvaist H, Brenner B, Couturaud F, Dellas C, Empen K, Franca A, Galie N, Geibel A, Goldhaber SZ, Jimenez D, Kozak M, Kupatt C, Kucher N, Lang IM, Lankeit M, Meneveau N, Pacouret G, Palazzini M, Petris A, Pruszczyk P, Rugolotto M, Salvi A, Schellong S, Sebbane M, Sobkowicz B, Stefanovic BS, Thiele H, Torbicki A, Verschuren F, Konstantinides SV (2014) Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 370:1402–1411CrossRef
13.
go back to reference Levine MN, Goldhaber SZ, Califf RM, Gore JM, Hirsh J (1992) Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism. Chest 102:364S–373SCrossRef Levine MN, Goldhaber SZ, Califf RM, Gore JM, Hirsh J (1992) Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism. Chest 102:364S–373SCrossRef
14.
go back to reference Berkowitz SD, Granger CB, Pieper KS, Lee KL, Gore JM, Simoons M, Armstrong PW, Topol EJ, Califf RM (1997) Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO) I investigators. Circulation 95:2508–2516CrossRef Berkowitz SD, Granger CB, Pieper KS, Lee KL, Gore JM, Simoons M, Armstrong PW, Topol EJ, Califf RM (1997) Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO) I investigators. Circulation 95:2508–2516CrossRef
Metadata
Title
Diffuse alveolar hemorrhage following intravenous thrombolytic treatment in acute ischemic stroke: a case series
Authors
Murat Mert Atmaca
Ugur Burak Simsek
Ipek Midi
Rustem Aliev
Emrah Aytac
Mehtap Kocaturk
Publication date
01-01-2020
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 1/2020
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-019-03997-y

Other articles of this Issue 1/2020

Neurological Sciences 1/2020 Go to the issue

Acknowledgement to referees

Message from the editor-in-chief, 2020